| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Masnon Nurul-Ain, Zuhratun Nazihah Khairul Kamal, Wan-Hazabbah Wan Hitam, Maimunah Abd Munaaim, Faizah Mohd Zak. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Cureus. vol 13. issue 4. 2021-05-18. PMID:33996312. |
we noted multiple relapses of optic neuritis are common in mog patients. |
2021-05-18 |
2023-08-13 |
Not clear |
| Masnon Nurul-Ain, Zuhratun Nazihah Khairul Kamal, Wan-Hazabbah Wan Hitam, Maimunah Abd Munaaim, Faizah Mohd Zak. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Cureus. vol 13. issue 4. 2021-05-18. PMID:33996312. |
mog optic neuritis is a devastating, but treatable condition. |
2021-05-18 |
2023-08-13 |
Not clear |
| Masnon Nurul-Ain, Zuhratun Nazihah Khairul Kamal, Wan-Hazabbah Wan Hitam, Maimunah Abd Munaaim, Faizah Mohd Zak. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Cureus. vol 13. issue 4. 2021-05-18. PMID:33996312. |
aggressive treatment during acute optic neuritis attack and relapse prevention may favour a good visual prognosis in mog antibody disease. |
2021-05-18 |
2023-08-13 |
Not clear |
| Mathias Falck Schmidt, Gorm Pihl-Jensen, Margrethe Bastholm Bille, Jette Lautrup Frederikse. Anti-myelin oligodendrocyte glycoprotein antibodies in a girl with good recovery after five episodes of prior idiopathic optic neuritis. American journal of ophthalmology case reports. vol 22. 2021-05-18. PMID:33997466. |
to describe the clinical, radiological, immunological and electrophysiological features of a myelin oligodendrocyte glycoprotein (mog)-igg positive girl with five prior episodes of idiopathic bilateral optic neuritis (on). |
2021-05-18 |
2023-08-13 |
Not clear |
| Amir R Vosoughi, Jonathan A Miciel. Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment. Multiple sclerosis and related disorders. vol 46. 2021-05-14. PMID:32853896. |
resolution of myelin oligodendrocyte glycoprotein (mog)-igg optic neuritis without treatment. |
2021-05-14 |
2023-08-13 |
Not clear |
| Takaaki Nakamura, Kimihiko Kaneko, Genya Watanabe, Shogo Harashima, Emiko Kawasaki, Kenichi Tsukita, Toshiyuki Takahashi, Ichiro Nakashima, Tatsuro Misu, Yasushi Suzuk. Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 42. issue 3. 2021-05-14. PMID:33078247. |
myelin oligodendrocyte glycoprotein (mog)-igg detected by the cell-based assay is associated with demyelinating diseases of the central nervous system, such as optic neuritis, myelitis, and acute disseminated encephalomyelitis, but rarely with peripheral neuropathy. |
2021-05-14 |
2023-08-13 |
Not clear |
| Yeon Ji Jang, Sung-Min Kim, Seong-Joon Kim, Jae Ho Jun. Microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (MOG) antibody-associated optic neuritis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 42. issue 5. 2021-05-14. PMID:33211210. |
microcytic abnormalities of the inner retina in a patient with myelin oligodendrocyte glycoprotein (mog) antibody-associated optic neuritis. |
2021-05-14 |
2023-08-13 |
Not clear |
| Tomoaki Shima, Akira Tsujin. MOG antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: A case report. Multiple sclerosis and related disorders. vol 46. 2021-05-14. PMID:33296991. |
mog antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: a case report. |
2021-05-14 |
2023-08-13 |
Not clear |
| Tomoaki Shima, Akira Tsujin. MOG antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy: A case report. Multiple sclerosis and related disorders. vol 46. 2021-05-14. PMID:33296991. |
we herein present the case of a patient with mog antibody-related disease with recurrent optic neuritis and sensory polyradiculoneuropathy unaccompanied by cns lesions. |
2021-05-14 |
2023-08-13 |
Not clear |
| A Sebastian Lopez-Chiriboga, Gregory Van Stavern, Eoin P Flanagan, Sean J Pittock, Jim Fryer, M Tariq Bhatti, John J Che. Myelin Oligodendrocyte Glycoprotein Antibody (MOG-IgG)-Positive Optic Perineuritis. Neuro-ophthalmology (Aeolus Press). vol 44. issue 1. 2021-05-07. PMID:32076441. |
myelin oligodendrocyte glycoprotein (mog)-igg-positive optic neuritis has been reported to be associated with optic nerve sheath enhancement. |
2021-05-07 |
2023-08-13 |
Not clear |
| John J Chen, Sean J Pittock, Eoin P Flanagan, Vanda A Lennon, M Tariq Bhatt. Optic neuritis in the era of biomarkers. Survey of ophthalmology. vol 65. issue 1. 2021-03-03. PMID:31425702. |
subsequently, myelin oligodendrocyte glycoprotein (mog) igg was recognized to be a marker for mog-igg-associated disorder, a central demyelinating disease characterized by recurrent optic neuritis, prominent disk edema, and perineural optic nerve enhancement on magnetic resonance imaging. |
2021-03-03 |
2023-08-13 |
Not clear |
| Sotaro Mori, Takuji Kurimoto, Yusuke Murai, Kaori Ueda, Mari Sakamoto, Norio Chihara, Yuko Yamada-Nakanishi, Makoto Nakamur. Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis. Journal of ophthalmology. vol 2020. 2021-02-26. PMID:33628473. |
although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (on) after the completion of acute-phase treatment, especially anti-aquaporin 4 (aqp4) antibody-positive on, and anti-myelin oligodendrocyte glycoprotein (mog) antibody-positive on, some patients experience relapses. |
2021-02-26 |
2023-08-13 |
Not clear |
| John J Chen, M Tariq Bhatt. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Current opinion in neurology. vol 33. issue 1. 2021-01-22. PMID:31743235. |
to review the clinical characteristics, radiological manifestations and treatment of myelin oligodendrocyte glycoprotein (mog)-immunoglobulin g (igg) optic neuritis. |
2021-01-22 |
2023-08-13 |
Not clear |
| Liming Cao, Lijie Ren, Xuming Huan. Clinical analysis of a patient simultaneously positive for antibodies of myelin oligodendrocyte glycoprotein and anti-N-methyl-D-aspartate receptor: A case report. Medicine. vol 100. issue 1. 2021-01-22. PMID:33429822. |
myelin oligodendrocyte glycoprotein (mog) antibody (mog-ab) disease (mog-ad) is a type of demyelinating disease of the central nervous system characterized by a high frequency of optic neuritis (on) attacks. |
2021-01-22 |
2023-08-13 |
Not clear |
| Mohamed B Hassan, Caroline Stern, Eoin P Flanagan, Sean J Pittock, Amy Kunchok, Robert C Foster, Jiraporn Jitprapaikulsan, David O Hodge, M Tariq Bhatti, John J Che. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. American journal of ophthalmology. vol 220. 2020-12-22. PMID:32707199. |
to re-evaluate the population-based incidence of optic neuritis in the era of aquaporin-4-immunoglobulin g (aqp4-igg) and myelin oligodendrocyte glycoprotein (mog)-igg, which are biomarkers of optic neuritis that is distinct from multiple sclerosis (ms). |
2020-12-22 |
2023-08-13 |
Not clear |
| Khalid Sawalha, Stephen Adeodokun, Gilbert-Roy Kamog. COVID-19-Induced Acute Bilateral Optic Neuritis. Journal of investigative medicine high impact case reports. vol 8. 2020-12-22. PMID:33238757. |
whether this was an optic neuritis due to covid-19, mog antibody disease, or an activation of mog antibody disease by covid-19 is discussed in this case. |
2020-12-22 |
2023-08-13 |
Not clear |
| Yoshiki Takai, Tatsuro Misu, Kimihiko Kaneko, Norio Chihara, Koichi Narikawa, Satoko Tsuchida, Hiroya Nishida, Takashi Komori, Morinobu Seki, Teppei Komatsu, Kiyotaka Nakamagoe, Toshimasa Ikeda, Mari Yoshida, Toshiyuki Takahashi, Hirohiko Ono, Shuhei Nishiyama, Hiroshi Kuroda, Ichiro Nakashima, Hiroyoshi Suzuki, Monika Bradl, Hans Lassmann, Kazuo Fujihara, Masashi Aok. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain : a journal of neurology. vol 143. issue 5. 2020-12-14. PMID:32412053. |
conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (mog) are detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic disseminated encephalomyelitis (adem/mdem) and brainstem/cerebral cortical encephalitis, but are rarely detected in patients with prototypic multiple sclerosis. |
2020-12-14 |
2023-08-13 |
Not clear |
| Athanasios Papathanasiou, Radu Tanasescu, Jillian Davis, Maria Francisca Rocha, Sumeet Singhal, Michael F O'Donoghue, Cris S Constantinesc. MOG-IgG-associated demyelination: focus on atypical features, brain histopathology and concomitant autoimmunity. Journal of neurology. vol 267. issue 2. 2020-11-23. PMID:31641876. |
antibodies to myelin oligodendrocyte glycoprotein (mog) have been demonstrated in patients with optic neuritis (on), encephalitis and myelitis. |
2020-11-23 |
2023-08-13 |
Not clear |
| Brigitte Wildemann, Solveig Horstmann, Mirjam Korporal-Kuhnke, Andrea Viehöver, Sven Jariu. [Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis: Diagnosis and Treatment]. Klinische Monatsblatter fur Augenheilkunde. vol 237. issue 11. 2020-11-19. PMID:33202462. |
optic neuritis (on) is a frequent manifestation of aquaporin-4 (aqp4) antibody-mediated neuromyelitis optica spectrum disorders (nmosd) and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (mog-em; also termed mog antibody-associated disorders, mogad). |
2020-11-19 |
2023-08-13 |
Not clear |
| Rana K Zabad, Renee Stewart, Kathleen M Heale. Pattern Recognition of the Multiple Sclerosis Syndrome. Brain sciences. vol 7. issue 10. 2020-09-30. PMID:29064441. |
these antibody-mediated inflammatory diseases of the cns share a clinical presentation to ms. a number of practical learning points emerge in this review, which is geared toward the pattern recognition of optic neuritis, transverse myelitis, brainstem/cerebellar and hemispheric tumefactive demyelinating lesion (tdl)-associated ms, aquaporin-4-antibody and myelin oligodendrocyte glycoprotein (mog)-antibody nmosd, overlap syndrome, and some yet-to-be-defined/classified demyelinating disease, all unspecifically labeled under |
2020-09-30 |
2023-08-13 |
Not clear |